To view this email as a web page, click here.

You are subscribed to the Drug Topics eNews.

Drug Topics

Share

Download Magazine

Subscribe: Print / Digital   eNews

Community Pharmacists’ Report

COMMUNITY REPORT

New Hampshire medical board rejects strict opioid Rx proposal

Instead, board adopts rules that are less stringent than those proposed by Gov. Maggie Hassan. More

CONTINUING EDUCATION

Recognizing drug-induced pulmonary disease and managing idiopathic pulmonary fibrosis

The goal of this activity is to review the common medications associated with pulmonary toxicity and to review how to recognize and treat idiopathic pulmonary fibrosis. More

EDITOR'S CHOICE

5 things pharmacists should know about biosimilars

Erika Lietzan, JD, associate professor at the University of Missouri School of Law, provides legal guidance for pharmacists. More

Inside The Latest Issue

Medical marijuana: A new business model for pharmacists

Case study from an integrative pharmacy

Sacubitril/valsartan approved to treat heart failure

November 12, 2015

Advertisement

Continuing education

Recognition of drug-induced pulmonary disease and management of idiopathic pulmonary fibrosis

MTM essentials for cold, flu, and sinusitis management

MTM essentials for allergic rhinitis management

Get the free app!



Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us